UTI in Children: Clinical Case and Viva Q&A
1. Clinical Case of UTI in Children
Clinical Case: Urinary Tract Infection in a 3-year-old Girl
Patient Information:
- Name: Sarah Johnson
- Age: 3 years
- Sex: Female
Chief Complaint:
Fever, frequent urination, and abdominal pain for the past 2 days.
History of Present Illness:
Sarah's mother reports that her daughter has been experiencing a high fever (up to 39.5°C) for the past 48 hours. The child has been urinating more frequently than usual, often complaining of pain or discomfort while doing so. Sarah has also been holding her lower abdomen and crying intermittently. The mother noticed that Sarah's urine has a strong, unpleasant odor.
Past Medical History:
- No previous UTIs
- Up-to-date on vaccinations
- No known allergies
Physical Examination:
- Temperature: 39.2°C
- Heart Rate: 110 bpm
- Respiratory Rate: 24 breaths/min
- Blood Pressure: 95/60 mmHg
- Abdominal examination: Mild suprapubic tenderness
- No costovertebral angle tenderness
Laboratory Tests:
- Urinalysis:
- Leukocyte esterase: Positive
- Nitrites: Positive
- WBC: >20 per high-power field
- RBC: 5-10 per high-power field
- Complete Blood Count:
- WBC: 14,500/μL with left shift
- Hemoglobin: 12.5 g/dL
- Platelets: 280,000/μL
- C-reactive protein: 3.5 mg/dL (elevated)
Diagnosis:
Acute urinary tract infection (likely pyelonephritis)
Treatment Plan:
- Initiate empiric antibiotic therapy with oral cefixime 8 mg/kg/day divided into two doses for 10 days.
- Encourage increased fluid intake.
- Administer acetaminophen for fever and discomfort.
- Obtain urine culture and adjust antibiotics based on sensitivity results if necessary.
- Schedule follow-up in 48-72 hours to assess clinical improvement.
- Consider renal ultrasound to evaluate for anatomical abnormalities or complications.
Follow-up:
Sarah's symptoms improved significantly after 48 hours of antibiotic therapy. Urine culture grew Escherichia coli, sensitive to cefixime. She completed the 10-day course of antibiotics without complications. A follow-up urinalysis 2 weeks after completion of treatment was normal.
2. Clinical Presentations of UTI in Children
Clinical Presentations of UTI in Children
-
Classic Symptomatic UTI in Older Children:
- Dysuria (painful urination)
- Frequency and urgency
- Lower abdominal or suprapubic pain
- Low-grade fever
- Cloudy or strong-smelling urine
-
Febrile UTI / Pyelonephritis in Infants and Young Children:
- High fever (>39°C / 102.2°F)
- Irritability or lethargy
- Poor feeding
- Vomiting
- Abdominal pain or flank pain
- Failure to thrive
-
Asymptomatic Bacteriuria:
- No clinical symptoms
- Positive urine culture (discovered incidentally)
- More common in girls
-
UTI in Neonates:
- Nonspecific symptoms: poor feeding, vomiting, jaundice
- Temperature instability (hypothermia or hyperthermia)
- Lethargy or irritability
- Failure to thrive
- Sepsis-like presentation
-
Recurrent UTI with Underlying Abnormalities:
- History of multiple UTI episodes
- Enuresis or daytime incontinence
- Weak urine stream
- Incomplete bladder emptying
- Urinary retention
- Possible signs of vesicoureteral reflux or other anatomical abnormalities
-
UTI in Children with Neurogenic Bladder:
- Change in usual bladder or bowel habits
- Increased urinary incontinence
- Increased spasticity in children with spinal cord issues
- Autonomic dysreflexia in susceptible individuals
- Fever may or may not be present
-
UTI Associated with Dysfunctional Elimination Syndrome:
- History of constipation
- Daytime wetting or enuresis
- Frequent urge to urinate
- Holding maneuvers (e.g., squatting, crossing legs)
- Recurrent UTIs
3. Viva Questions and Answers on UTI in Children
Viva Questions and Answers on UTI in Children
-
Q: What are the most common causative organisms for UTI in children?
A: The most common causative organisms for UTI in children are:
- Escherichia coli (80-90% of cases)
- Klebsiella species
- Proteus mirabilis
- Enterococcus species
- Pseudomonas aeruginosa (more common in hospital-acquired infections or children with urological abnormalities)
-
Q: How does the prevalence of UTI differ between boys and girls at different ages?
A: The prevalence of UTI varies by age and sex:
- In the first year of life: Boys (3.7%) > Girls (2%)
- 1-5 years: Girls (3%) > Boys (1-2%)
- School-age children: Girls (1-3%) >> Boys (0.1-0.2%)
This difference is attributed to anatomical factors, with girls having a shorter urethra closer to the anus.
-
Q: What are the risk factors for UTI in children?
A: Risk factors for UTI in children include:
- Vesicoureteral reflux (VUR)
- Urinary tract obstruction or stasis
- Neurogenic bladder
- Constipation
- Dysfunctional voiding
- Uncircumcised males (in the first year of life)
- Sexual activity in adolescents
- Previous UTIs
- Immunocompromised state
-
Q: How do you differentiate between upper and lower UTI in children?
A: Differentiation between upper and lower UTI:
- Upper UTI (pyelonephritis):
- High fever (>39°C / 102.2°F)
- Flank pain or costovertebral angle tenderness
- Systemic symptoms (vomiting, lethargy)
- Elevated inflammatory markers (CRP, ESR)
- Lower UTI (cystitis):
- Low-grade or no fever
- Dysuria, frequency, urgency
- Suprapubic pain
- Absence of systemic symptoms
- Upper UTI (pyelonephritis):
-
Q: What is the gold standard for diagnosing UTI in children?
A: The gold standard for diagnosing UTI in children is a positive urine culture with significant bacterial growth from a properly collected urine sample. Significance is defined as:
- >100,000 CFU/mL from a clean-catch midstream urine sample
- >50,000 CFU/mL from a catheterized sample
- Any growth from a suprapubic aspiration
-
Q: What are the recommended methods for urine collection in children of different ages?
A: Recommended methods for urine collection by age:
- Infants and non-toilet trained children: Suprapubic aspiration (most accurate) or urethral catheterization
- Toilet-trained children: Clean-catch midstream urine sample
- Urine bags are not recommended for diagnosis due to high contamination rates
-
Q: What are the key components of urinalysis in suspected UTI?
A: Key components of urinalysis in suspected UTI:
- Leukocyte esterase (indicator of WBCs)
- Nitrites (produced by many gram-negative bacteria)
- Microscopy for WBCs and bacteria
- Presence of red blood cells
A positive leukocyte esterase and/or nitrite test has high sensitivity and specificity for UTI.
-
Q: What imaging studies are recommended for children with UTI?
A: Imaging recommendations for children with UTI:
- Renal and bladder ultrasound: Recommended for all children with first febrile UTI
- Voiding cystourethrogram (VCUG): Consider in children with recurrent UTIs, abnormal ultrasound findings, or risk factors for vesicoureteral reflux
- DMSA scan: May be used to detect renal scarring, typically 4-6 months after acute pyelonephritis
-
Q: What are the current recommendations for empiric antibiotic treatment of UTI in children?
A: Empiric antibiotic recommendations for UTI in children:
- Oral therapy for uncomplicated UTI:
- First-line: Trimethoprim-sulfamethoxazole or nitrofurantoin
- Alternatives: Cephalexin, amoxicillin-clavulanate
- Parenteral therapy for complicated or severe UTI:
- Ceftriaxone, cefotaxime, or ampicillin plus gentamicin
- Duration: 7-14 days for pyelonephritis, 3-5 days for cystitis
Note: Local antibiotic resistance patterns should guide empiric therapy choices.
- Oral therapy for uncomplicated UTI:
-
Q: What is vesicoureteral reflux (VUR) and how does it relate to UTI in children?
A: Vesicoureteral reflux (VUR) is the retrograde flow of urine from the bladder into the ureters and kidneys. It is significant in UTI because:
- It is present in 30-40% of children with UTI
- Increases risk of pyelonephritis and renal scarring
- Can be primary (congenital) or secondary (due to bladder dysfunction)
- Graded I-V based on severity (International Reflux Study classification)
- Management depends on grade, age, and presence of renal scarring
-
Q: How do you manage asymptomatic bacteriuria in children?
A: Management of asymptomatic bacteriuria in children:
- Generally, no treatment is recommended
- Exceptions: pregnant adolescents or children undergoing urologic procedures
- Treating asymptomatic bacteriuria can lead to antibiotic resistance and more symptomatic infections
- Regular follow-up to ensure it remains asymptomatic
- Evaluate for underlying urological abnormalities if persistent
-
Q: What are the potential long-term complications of recurrent UTIs in children?
A: Potential long-term complications of recurrent UTIs include:
- Renal scarring, which can lead to:
- Hypertension
- Proteinuria
- Chronic kidney disease
- Growth retardation
- Recurrent abdominal and flank pain
- Increased risk of pre-eclampsia in adulthood
- Psychological impact (anxiety, school absenteeism)
- Renal scarring, which can lead to:
-
Q: What is the role of prophylactic antibiotics in preventing recurrent UTIs in children?
A: The role of prophylactic antibiotics in preventing recurrent UTIs:
- Currently, routine antibiotic prophylaxis is not recommended for all children after a first UTI
- May be considered in select cases:
- Children with high-grade vesicoureteral reflux
- Recurrent UTIs (≥3 per year)
- Significant urological abnormalities
- Common prophylactic antibiotics: trimethoprim-sulfamethoxazole, nitrofurantoin
- Risks include antibiotic resistance and alteration of gut microbiome
- Decision should be individualized based on risk-benefit analysis
-
Q: How does dysfunctional elimination syndrome contribute to UTIs in children?
A: Dysfunctional elimination syndrome and UTIs:
- Characterized by abnormal voiding patterns and often associated with constipation
- Contributes to UTIs through:
- Incomplete bladder emptying, leading to urinary stasis
- Increased bladder pressure, potentially causing vesicoureteral reflux
- Constipation causing mechanical compression of the bladder and bacterial translocation
- Management includes:
- Timed voiding
- Double voiding
- Treatment of constipation
- Pelvic floor physical therapy in some cases
-
Q: What are the indications for DMSA (dimercaptosuccinic acid) renal scan in pediatric UTI?
A: Indications for DMSA renal scan in pediatric UTI:
- To detect acute pyelonephritis when diagnosis is uncertain
- To identify renal scarring, typically 4-6 months after acute pyelonephritis
- To assess differential renal function in children with vesicoureteral reflux
- In research settings to evaluate the effectiveness of UTI treatment strategies
- Not routinely recommended after first febrile UTI unless abnormalities are seen on ultrasound
-
Q: How do you approach UTI management in children with neurogenic bladder?
A: Management of UTI in children with neurogenic bladder:
- Regular clean intermittent catheterization (CIC) to ensure complete bladder emptying
- Maintain low bladder pressures (may require anticholinergic medications)
- Consider antibiotic prophylaxis in selected cases
- Regular urodynamic studies to assess bladder function
- Treat asymptomatic bacteriuria only if symptomatic UTIs are frequent
- Surgical interventions (e.g., vesicostomy, augmentation cystoplasty) in refractory cases
-
Q: What are the current recommendations for circumcision in relation to UTI prevention?
A: Current recommendations for circumcision and UTI prevention:
- Circumcision reduces the risk of UTI, especially in the first year of life
- The American Academy of Pediatrics states that the health benefits outweigh the risks, but are not great enough to recommend routine circumcision
- May be considered in boys with recurrent UTIs or high-grade vesicoureteral reflux
- The decision should be made by parents in consultation with their healthcare provider, considering cultural, religious, and personal factors
-
Q: How do you diagnose and manage fungal UTIs in children?
A: Diagnosis and management of fungal UTIs in children:
- Diagnosis:
- Urine culture showing significant growth of Candida species
- Presence of pseudohyphae on microscopy
- Risk factors:
- Immunosuppression
- Prolonged antibiotic use
- Indwelling urinary catheters
- Management:
- Remove or change indwelling catheters if present
- Antifungal therapy: fluconazole or amphotericin B
- Duration of treatment: 7-14 days
- Evaluate for systemic candidiasis in high-risk patients
- Diagnosis:
-
Q: What are the differences in UTI presentation and management between infants and older children?
A: Differences in UTI presentation and management between infants and older children:
- Presentation:
- Infants: Often nonspecific (fever, irritability, poor feeding, vomiting)
- Older children: More specific urinary symptoms (dysuria, frequency, abdominal pain)
- Diagnosis:
- Infants: Catheterization or suprapubic aspiration for urine collection
- Older children: Clean-catch midstream urine samples are acceptable
- Management:
- Infants: Lower threshold for hospital admission and IV antibiotics
- Older children: Often managed as outpatients with oral antibiotics
- Imaging:
- Infants: More likely to undergo comprehensive imaging (ultrasound, VCUG)
- Older children: Imaging may be deferred unless recurrent or complicated UTIs
- Presentation:
-
Q: How do you approach antibiotic resistance in pediatric UTIs?
A: Approach to antibiotic resistance in pediatric UTIs:
- Monitor local antibiotic resistance patterns to guide empiric therapy
- Obtain urine cultures before starting antibiotics when possible
- Consider broader-spectrum antibiotics for hospital-acquired UTIs or children with frequent antibiotic exposure
- Adjust therapy based on culture and sensitivity results
- Avoid overuse of broad-spectrum antibiotics to prevent further resistance
- Educate families on proper antibiotic use and the importance of completing prescribed courses
- Consider antibiotic cycling in hospital settings to reduce resistance
-
Q: What are the current guidelines for follow-up imaging after a first febrile UTI in children?
A: Current guidelines for follow-up imaging after a first febrile UTI:
- Renal and bladder ultrasound:
- Recommended for all children after first febrile UTI
- Timing: Can be done during or shortly after treatment
- Voiding cystourethrogram (VCUG):
- Not routinely recommended after a single febrile UTI
- Consider if ultrasound shows hydronephrosis, scarring, or other abnormalities
- Recommended for recurrent febrile UTIs
- DMSA scan:
- Not routinely recommended after a single febrile UTI
- Consider 4-6 months after acute pyelonephritis to assess for renal scarring in high-risk cases
Note: These guidelines are based on the AAP (American Academy of Pediatrics) recommendations, but practices may vary internationally.
- Renal and bladder ultrasound:
-
Q: What are the non-antibiotic strategies for preventing recurrent UTIs in children?
A: Non-antibiotic strategies for preventing recurrent UTIs:
- Proper hygiene:
- Wiping front to back after toileting
- Regular bathing
- Hydration: Encourage adequate fluid intake
- Voiding habits:
- Regular and complete bladder emptying
- Avoid holding urine for long periods
- Treat constipation if present
- Cranberry products: Limited evidence, but may be beneficial in some cases
- Probiotics: Emerging evidence, but role not yet clearly defined
- Address dysfunctional elimination syndrome if present
- Consider vitamin A supplementation in select cases (some evidence of benefit)
- Proper hygiene:
-
Q: How do you manage UTIs in children with urinary tract anomalies?
A: Management of UTIs in children with urinary tract anomalies:
- Individualized approach based on the specific anomaly
- Common anomalies include:
- Vesicoureteral reflux (VUR)
- Posterior urethral valves
- Ureteropelvic junction obstruction
- Management strategies:
- Prompt and appropriate antibiotic treatment for UTIs
- Consider antibiotic prophylaxis in select cases
- Regular monitoring with ultrasound and other imaging as needed
- Surgical correction of the anomaly if indicated
- Clean intermittent catheterization for some conditions
- Close follow-up with pediatric urologist or nephrologist
- Educate families on signs of UTI and importance of prompt treatment
- Monitor renal function and growth
-
Q: What is the role of biomarkers in diagnosing and managing pediatric UTIs?
A: Role of biomarkers in pediatric UTIs:
- Procalcitonin (PCT):
- Can help differentiate upper from lower UTI
- Higher levels associated with renal parenchymal involvement
- May guide duration of antibiotic therapy
- C-reactive protein (CRP):
- Elevated in pyelonephritis
- Less specific than PCT
- Neutrophil gelatinase-associated lipocalin (NGAL):
- Promising biomarker for early detection of UTI
- May help predict severity and risk of renal scarring
- Interleukin-6 (IL-6) and Interleukin-8 (IL-8):
- Elevated in acute pyelonephritis
- May help in early identification of kidney involvement
Note: While these biomarkers show promise, they are not yet routinely used in all clinical settings and require further validation in large-scale studies.
- Procalcitonin (PCT):
